据"北京亦庄"消息，1月23日至24日，第三届北京商业航天产业高质量发展推进会将在北京经开区举 办。本次大会以"聚力赋新 质向空天"为主题，将设置成果发布、主旨报告、专题座谈等多个环节，邀 请政府部门、航天院所、领军企业及金融机构等多方代表参与，共探技术变革新趋势、共绘产业发展新 图景。大会现场，北京经开区将正式发布多个创新服务平台，进一步优化北京火箭大街发展生态。 NO.2 银河证券：商业航天产业正迈入需求侧与供给侧双向发力的黄金时代 每经记者｜杨建 每经编辑｜肖芮冬 ｜2026年1月23日 星期五｜ NO.1 第三届北京商业航天产业高质量发展推进会将在北京举办 1月22日，高盛将黄金今年底目标价从每盎司4900美元上调至5400美元，理由是私人部门投资者和中央 银行对黄金的需求不断增长。高盛分析师在报告中指出，预计各国央行今年每月将购买60吨黄金，同时 随着美联储降息，黄金ETF的持有量也将增加。高盛分析师称，各国央行已开始通过传统的ETF，与私 人部门投资者争夺有限的黄金。 NO.7 我国制冷技术新突破，有望推动算力基础设施低碳运行 1月22日，从中国科学院金属研究所获悉，近日，该研究所李昺研究员团队与 ...

Core Insights - The establishment of the "Fifth Batch of National Regional Medical Centers" in Loudi, Hunan, represents a significant step towards improving local healthcare access and quality, with Guangzhou Medical University Affiliated First Hospital leading the initiative [1] - The hospital will focus on respiratory care, urology, thoracic surgery, critical care, infectious diseases, and emergency rescue, aiming to serve nearly 20 million people in Hunan and surrounding provinces [1] - The project, with a total investment of 2.234 billion yuan, is set to be operational by June 2026, addressing the uneven distribution of medical resources and enhancing the capacity of quality healthcare services [1] Group 1 - The hospital will have 1,200 beds and has already implemented 53 new medical technologies, filling several local healthcare gaps [1] - A "Lung Health" project has screened over 8,700 individuals for chronic obstructive pulmonary disease and lung cancer, promoting proactive disease prevention [1] - The hospital has conducted over 70 remote consultations and regular "Academician Grand Rounds" under the guidance of renowned experts like Academician Zhong Nanshan [1] Group 2 - The hospital's advancements include minimally invasive surgeries, such as a complex thoracoscopic procedure that allows patients to recover quickly without the need for extensive travel [2] - The shift from a "blood transfusion" model to a "blood production" model has been crucial, with over 500 expert visits and training for 319 local staff to enhance local medical capabilities [2] - The establishment of 73 tightly-knit medical alliances has expanded healthcare access to rural areas, with over 12,000 remote consultations and significant cost savings for patients [3] Group 3 - Since 2025, the proportion of outpatient patients from outside the city has increased to 12.46%, while the number of out-of-city inpatient cases has decreased by 2,566, saving 37.88 million yuan in medical expenses [3] - The initiative aligns with the broader goal of building a healthier China, with ongoing projects like the "Guangzhou Laboratory Tuberculosis Prevention Base" aiming to enhance community health [3] - The commitment to "people first, life first" underscores the hospital's dedication to providing equitable healthcare services to all families [3]

Core Insights - The rapid advancement of AI technology and the era of big data are accelerating the application of AI in the healthcare sector, with significant developments such as the establishment of AI hospitals and the deployment of AI diagnostic systems in major hospitals [1] Group 1: AI in Healthcare Services - The National Health Commission has introduced 84 application scenarios for AI in healthcare, including intelligent pre-consultation, intelligent accompaniment, and decision support systems, which have been implemented in various hospitals [1] - In Jinan, the "intelligent pre-consultation" system enhances communication between patients and doctors, making the consultation process more efficient [2] - AI follow-up systems have been implemented in 43 clinical departments at Sichuan University West China Hospital, serving 500,000 patients and making 793,000 automated follow-up calls by November 2025 [2] Group 2: Efficiency in Diagnosis and Treatment - AI is enhancing diagnostic efficiency, exemplified by the rapid assessment of acute ischemic stroke imaging at Beijing Tiantan Hospital, which can be completed in three minutes, halving the decision-making time for surgeries [3] - AI psychological service robots are providing support to patients, helping them manage anxiety and other mental health issues during their hospital stay [3] Group 3: Future Prospects of AI in Healthcare - The integration of AI in healthcare is expected to improve diagnostic efficiency and optimize resource allocation, contributing to high-quality development in the health sector [5] - The implementation of AI in various healthcare applications, including clinical diagnosis and public health, is being promoted by national policies aimed at fostering a robust health industry [5] Group 4: Boundaries of AI Application - Current regulations stipulate that AI cannot replace physicians in providing diagnostic services, and prescriptions must be issued by licensed medical professionals [7] - AI is primarily a supportive tool in clinical decision-making, enhancing the capabilities of healthcare professionals rather than replacing them [8] Group 5: Legal and Ethical Considerations - Medical institutions remain the primary responsible entities in cases of medical accidents involving AI, emphasizing that AI serves as an auxiliary tool for healthcare providers [9] - Legal frameworks are needed to address the complexities of AI in healthcare, including liability issues and the need for clear standards for responsibility [10] Group 6: Patient Privacy Protection - The protection of patient privacy is critical, with a consensus on the need for robust data security measures and adherence to ethical standards in handling sensitive health information [11] - Various hospitals are exploring innovative solutions, such as blockchain technology, to ensure data integrity and patient anonymity [11]

Group 1 - Southbound funds increased their holdings in Jinxin Fertility (01951.HK) by 5.839 million shares on January 22 [1] - Over the past five trading days, southbound funds have increased their holdings for four days, with a total net increase of 9.23 million shares [1] - In the last 20 trading days, there were 11 days of net reductions by southbound funds, totaling 9.282 million shares [1] Group 2 - As of now, southbound funds hold 1.453 billion shares of Jinxin Fertility, accounting for 52.69% of the company's issued ordinary shares [1] - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment, mainly in China and the United States [1]

1月22日阳光诺和大宗交易一览 | 成交量 | 成交金额 | 成交价格 | 相对当日收盘折 | 买方营 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | （万股） | （万元） | （元） | 溢价（%） | 业部 | | | 50.00 | 3575.50 | 71.51 | -1.50 | 机构专 | 东吴证券股份有限公司苏州工业园 | | | | | | 用 | 区扬富路证券营业部 | （文章来源：证券时报网） 证券时报·数据宝统计显示，阳光诺和今日收盘价为72.60元，下跌0.47%，日换手率为2.65%，成交额为 2.17亿元，全天主力资金净流入951.48万元，近5日该股累计下跌3.90%，近5日资金合计净流入362.16万 元。 两融数据显示，该股最新融资余额为6.91亿元，近5日增加1762.94万元，增幅为2.62%。 据天眼查APP显示，北京阳光诺和药物研究股份有限公司成立于2009年03月09日，注册资本11200万人 民币。（数据宝） 阳光诺和1月22日大宗交易平台出现一笔成交，成交量50.00万股，成交金额3575.50万元，大宗交易 ...

Core Viewpoint - The company has been deeply engaged in the healthcare industry for over 20 years, providing comprehensive healthcare services from life conception to health management, medical services to rehabilitation and elderly care [1] Group 1: Business Focus - The company is actively exploring diversified service models, including home visits, continuous care, and internet healthcare, to meet the personalized healthcare needs of different patients [1] - Future business expansion will focus on high-level medical services and will include life health management, integrated medical and elderly care, and smart health management to better serve the aging population [1]

Core Viewpoint - Samsung Medical (601567) is focusing on the development of high-quality rehabilitation specialty chains, emphasizing critical rehabilitation, neurological rehabilitation, and functional rehabilitation, with a foundation in elderly rehabilitation [1] Group 1: Company Strategy - The company has been deeply involved in the medical services sector for many years, focusing on the construction, operation, and investment mergers and acquisitions of physical medical institutions [1] - Samsung Medical is continuously expanding its presence in key regions such as the Yangtze River Delta and the Pearl River Delta [1] Group 2: Operational Highlights - As of now, the company operates a total of 38 hospitals, including 32 rehabilitation hospitals [1] - The total number of beds across these hospitals has exceeded 10,000 [1]

（来源：北京新闻广播） 【让"生或不生"不再是"盲选"！#北京政协委员提案AI助产检准度或超90%#】 产检"正常"，为何新生儿 仍面临重症？残酷的现实是：目前新生儿结构畸形产前诊断准确率仅为30%到60%，像食道闭锁等疾 病，检出率甚至低至20%~30%。北京市政协委员、首都儿童医学中心新生儿外科主任医师马立霜，结 合自己30年的临床经验，提出了这样一份提案：用AI赋能产前超声，建立结构畸形数据库，训练诊断 模型，目标是将准确率稳定提升至90%以上。跟随记者，直击新生儿重症监护室的生死时速，看这项技 术如何让"生或不生"不再是"盲选"。#和北京代表委员做一日朋友##直击2026北京两会# ...

据第一财经，1月22日，针对张文宏医生此前表示"拒绝将AI引入其所在医院电子病历系统"，担忧年轻 医生过度依赖AI并被误导的观点，百川智能创始人王小川在接受采访时表达了不同观点。他认为如果 担心医生成长而去限制AI，可能就限制了最有利于病人的医疗措施。"医生的成长是不能以当下患者作 为成本的。" （来源：智通财经） 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ ...

Core Viewpoint - The company has received approval for a private placement aimed at funding specific projects, including a smart healthcare initiative and the second phase of a proton therapy center, while also addressing liquidity needs [2] Group 1: Fundraising Details - The private placement has been approved by the company's 13th Board of Directors at its 9th meeting and the second extraordinary shareholders' meeting of 2025 [2] - The raised funds will be allocated specifically for the smart healthcare project, the second phase of the proton therapy center, and to supplement working capital [2] - According to the regulations on fundraising by listed companies, the use of raised funds must be strictly adhered to, and any significant adjustments to the planned use must follow legal procedures [2]